Full Text
A Dynamic Health Economics App- The Budget Impact Of Adopting The Recently Fda Approved Hepatitis C Therapy, Sofosbuvir To A United States Formulary

Abstract

Authors

M. Lingohr-Smith J. Lin

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×